News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
drugs pills and capsules

Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018

Good results from the drug Lonsurf for treating metastatic gastric cancer in a phase 3 trial are being presented this week at the ESMO 20th World Congress on Gastrointestinal Cancer (tag) 2018 in Barcelona, Spain.

Read Source
Please join with us to fuel the next wave of progress.

Your support honors the memories of those we have lost and creates much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2025 Fundraising Campaign.

Your support honors the memories of those we have lost and creates much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Powering progress to defeat stomach cancer.

Powering progress to defeat stomach cancer.

MORE INFODONATEDONATEMORE INFO
X